BARHL2
BarH-like 2 homeobox protein
Also known as: BARH2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NY43
- Gene
- BARHL2
- Ensembl
- ENSG00000143032
- Chromosome
- 1
- Canonical length
- 387 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including generation of neurons; positive regulation of macromolecule biosynthetic process; and regulation of axon extension. Predicted to be located in chromatin. Predicted to be active in nucleus. Implicated in oral squamous cell carcinoma. Biomarker of colorectal cancer; oral squamous cell carcinoma; and stomach cancer. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
387 residues, UniProt reviewed canonical sequence.
>Q9NY43|BARHL2
1 MTMEGASGSS FGIDTILSSA SSGSPGMMNG DFRPLGEART ADFRSQATPS PCSEIDTVGT
61 APSSPISVTM EPPEPHLVAD ATQHHHHLHH SQQPPPPAAA PTQSLQPLPQ QQQPLPPQQP
121 PPPPPQQLGS AASAPRTSTS SFLIKDILGD SKPLAACAPY STSVSSPHHT PKQESNAVHE
181 SFRPKLEQED SKTKLDKRED SQSDIKCHGT KEEGDREITS SRESPPVRAK KPRKARTAFS
241 DHQLNQLERS FERQKYLSVQ DRMDLAAALN LTDTQVKTWY QNRRTKWKRQ TAVGLELLAE
301 AGNYSALQRM FPSPYFYHPS LLGSMDSTTA AAAAAAMYSS MYRTPPAPHP QLQRPLVPRV
361 LIHGLGPGGQ PALNPLSSPI PGTPHPRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BARHL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 42 nTPM
- retina: 2.6 nTPM
- testis: 2.2 nTPM
- hypothalamus: 0.9 nTPM
- spinal cord: 0.7 nTPM
- midbrain: 0.3 nTPM
Single-cell type
- retinal horizontal cells: 40 nCPM
- retinal amacrine cells: 25 nCPM
- undifferentiated spermatogonia: 9.6 nCPM
- brain excitatory neurons: 9 nCPM
- early primary spermatocytes: 5.1 nCPM
- retinal ganglion cells: 3.9 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 57 nTPM
- midbrain: 4.3 nTPM
- thalamus: 4.3 nTPM
- pons: 4.2 nTPM
- hypothalamus: 2.7 nTPM
- cerebral cortex: 1.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.54
- gnomAD pLI
- 0.61
- gnomAD missense Z
- -0.06
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amacrine cell differentiation
- cell fate determination
- neuron migration
- positive regulation of translation
- regulation of axon extension
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Homeodomain
- Homedomain-like superfamily
- Homeobox, conserved site
- Homeodomain, metazoa
- Homeodomain
- Mediator complex and homeobox domain-containing protein
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BARHL2 as an antibody target. Whether an autoantibody or antibody against BARHL2 could matter depends on whether native BARHL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BARHL2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BARHL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...